136 related articles for article (PubMed ID: 37566445)
1. Exploring the Impact of Dawn Phenomenon on Glucose-Guided Eating Thresholds in Individuals With Type 2 Diabetes Using Continuous Glucose Monitoring: Observational Study.
Jospe MR; Marano KM; Bedoya AR; Behrens NL; Cigan L; Villegas V; Magee MF; Marrero DG; Richardson KM; Liao Y; Schembre SM
JMIR Form Res; 2023 Aug; 7():e46034. PubMed ID: 37566445
[TBL] [Abstract][Full Text] [Related]
2. Efficacy Comparison of Preprandial and Postprandial Prandilin 25 Administration in Patients with Newly Diagnosed Type 2 Diabetes Using a Continuous Glucose Monitoring System.
Luo Y; Ni WJ; Ding BO; Xu XH; Ye L; Ma JH; Zhu J
Diabetes Ther; 2019 Feb; 10(1):205-213. PubMed ID: 30610472
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. The dawn phenomenon in type 2 diabetes: how to assess it in clinical practice?
Monnier L; Colette C; Dejager S; Owens D
Diabetes Metab; 2015 Apr; 41(2):132-7. PubMed ID: 25457475
[TBL] [Abstract][Full Text] [Related]
5. Dual-basal-insulin regimen for the management of dawn phenomenon in children with type 1 diabetes: a retrospective cohort study.
Celik NB; Canoruc Emet D; Canturk M; Ozon ZA; Gonc EN
Ther Adv Endocrinol Metab; 2023; 14():20420188231220130. PubMed ID: 38152658
[TBL] [Abstract][Full Text] [Related]
6. Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(20):1-58. PubMed ID: 23074525
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
Matsuda E; Brennan P
JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
[TBL] [Abstract][Full Text] [Related]
8. Continuous Glucose Monitoring-Guided Insulin Administration in Hospitalized Patients With Diabetes: A Randomized Clinical Trial.
Spanakis EK; Urrutia A; Galindo RJ; Vellanki P; Migdal AL; Davis G; Fayfman M; Idrees T; Pasquel FJ; Coronado WZ; Albury B; Moreno E; Singh LG; Marcano I; Lizama S; Gothong C; Munir K; Chesney C; Maguire R; Scott WH; Perez-Guzman MC; Cardona S; Peng L; Umpierrez GE
Diabetes Care; 2022 Oct; 45(10):2369-2375. PubMed ID: 35984478
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Insulin Glargine 300 Units/mL and 100 Units/mL in Adults With Type 1 Diabetes: Continuous Glucose Monitoring Profiles and Variability Using Morning or Evening Injections.
Bergenstal RM; Bailey TS; Rodbard D; Ziemen M; Guo H; Muehlen-Bartmer I; Ahmann AJ
Diabetes Care; 2017 Apr; 40(4):554-560. PubMed ID: 28115474
[TBL] [Abstract][Full Text] [Related]
10. Severe dawn phenomenon predicts long-term risk of all-cause mortality in patients with type 2 diabetes.
Cai J; Peng P; Lu J; Shen Y; Wang C; Mo Y; Lu W; Zhu W; Xia T; Zhou J
Diabetes Metab Res Rev; 2024 May; 40(4):e3813. PubMed ID: 38767128
[TBL] [Abstract][Full Text] [Related]
11. Use of Factory-Calibrated Real-time Continuous Glucose Monitoring Improves Time in Target and HbA
Thabit H; Prabhu JN; Mubita W; Fullwood C; Azmi S; Urwin A; Doughty I; Leelarathna L
Diabetes Care; 2020 Oct; 43(10):2537-2543. PubMed ID: 32723843
[TBL] [Abstract][Full Text] [Related]
12. Study of Glycemic Variability in Well-controlled Type 2 Diabetic Patients Using Continuous Glucose Monitoring System.
Swami V; Yadav SK; Saxena P; Sharma A; Dash CK; Gupta A
J Assoc Physicians India; 2024 Jan; 72(1):18-21. PubMed ID: 38736069
[TBL] [Abstract][Full Text] [Related]
13. Effects of Exercise on Blood Glucose and Glycemic Variability in Type 2 Diabetic Patients with Dawn Phenomenon.
Zheng X; Qi Y; Bi L; Shi W; Zhang Y; Zhao D; Hu S; Li M; Li Q
Biomed Res Int; 2020; 2020():6408724. PubMed ID: 32149118
[TBL] [Abstract][Full Text] [Related]
14. Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size.
Jovanovic L; Giammattei J; Acquistapace M; Bornstein K; Sommermann E; Pettitt DJ
Clin Ther; 2004 Sep; 26(9):1492-7. PubMed ID: 15531011
[TBL] [Abstract][Full Text] [Related]
15. Glycaemia in low-premixed insulin analogue type 2 diabetes patients in a real-world setting: are the CGM targets met?
Krajnc M; Kravos Tramšek NA
Eur J Med Res; 2023 Mar; 28(1):111. PubMed ID: 36882852
[TBL] [Abstract][Full Text] [Related]
16. Contribution of the dawn phenomenon to the fasting and postbreakfast hyperglycemia in type 1 diabetes treated with once-nightly insulin glargine.
King AB; Clark D; Wolfe GS
Endocr Pract; 2012; 18(4):558-62. PubMed ID: 22548951
[TBL] [Abstract][Full Text] [Related]
17. Nocturnal blood glucose control in type I diabetes mellitus.
Bolli GB; Perriello G; Fanelli CG; De Feo P
Diabetes Care; 1993 Dec; 16 Suppl 3():71-89. PubMed ID: 8299480
[TBL] [Abstract][Full Text] [Related]
18. Nocturnal hypoglycemia is underdiagnosed in older people with insulin-treated type 2 diabetes: The HYPOAGE observational study.
Boureau AS; Guyomarch B; Gourdy P; Allix I; Annweiler C; Cervantes N; Chapelet G; Delabrière I; Guyonnet S; Litke R; Paccalin M; Penfornis A; Saulnier PJ; Wargny M; Hadjadj S; de Decker L; Cariou B
J Am Geriatr Soc; 2023 Jul; 71(7):2107-2119. PubMed ID: 36965179
[TBL] [Abstract][Full Text] [Related]
19. [The dawn or Somogyi phenomenon? High morning fasting blood sugar values in young type-1 diabetics].
Holl RW; Heinze E
Dtsch Med Wochenschr; 1992 Oct; 117(40):1503-7. PubMed ID: 1396135
[TBL] [Abstract][Full Text] [Related]
20. Effects of personalized diets by prediction of glycemic responses on glycemic control and metabolic health in newly diagnosed T2DM: a randomized dietary intervention pilot trial.
Rein M; Ben-Yacov O; Godneva A; Shilo S; Zmora N; Kolobkov D; Cohen-Dolev N; Wolf BC; Kosower N; Lotan-Pompan M; Weinberger A; Halpern Z; Zelber-Sagi S; Elinav E; Segal E
BMC Med; 2022 Feb; 20(1):56. PubMed ID: 35135549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
